MedPath

Database and Calibration of a Non-invasive Glucose Monitoring Device

Not Applicable
Completed
Conditions
Diabetes
Registration Number
NCT03362528
Lead Sponsor
RSP Systems A/S
Brief Summary

This clinical study has been launched to collect spectral raman data paired with validated glucose reference values in private homes of subjects.

Detailed Description

Subjects will collect 2-4 daily optical raman readings paired with capillary Blood Glucose comparator in own home with maintaining usual routines. Subjects will either collect data for 30 days during a 60 days period or collect data for 90 days during 6 months.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
12
Inclusion Criteria
  • Male and female subjects 18 years of age or older
  • Diabetic (all types) patients
Exclusion Criteria
  • Pregnant women
  • Subjects not able to understand and read Danish
  • In investigator's opinion, subject is not able to follow instructions as specified in the protocol
  • Subjects not able to hold hand/arm steadily
  • Extensive skin changes, tattoos or diseases on probe application site
  • Rejection by prescreening optical measurements
  • Known allergy to medical grade alcohol used to disinfect skin

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Generation and validation of predictive algorithms for determining blood glucose levels7 months

Collected spectral raman data will found the development of predictive algorithms for glucose determination. Performance of predictive models will be evaluated using the consensus error grid

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Department of Endocrinology M

🇩🇰

Odense, Denmark

Department of Endocrinology M
🇩🇰Odense, Denmark

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.